1738A heritage of Decision ScienceDaniel Bernoulli

For CEOs, senior executives and supervisory boards

Tracking changes in how CEOs make decisions.

We track individual changes in the decision-making behaviour of CEOs and other key decision-makers. We compare leadership-relevant decision tasks with your personal baseline and interpret the results in a medical context.

The reference is the individual’s own baseline: are reward valuation, willingness to exert effort, risk weighting or creative problem-solving changing?

Historical reference: Daniel Bernoulli’s theory of risk and utility, published in 1738.

Scientific heritage
A CEO in a dark suit speaks with an assessment specialist while a psychologist and a physician contribute to the evaluation in a spacious meeting room.

So executives can perform at the highest level when making critical decisions.

  1. Baseline

    Two initial assessments

  2. Track

    Annual and event-triggered comparisons

  3. Interpret

    Professional assessment and independent second review

The person behind the company’s decisions also deserves attention.

Companies regularly review their financial and operational results. We focus on the person behind them: how is decision-making changing in the individual who materially influences those results?

This is where Cognitive Due Diligence comes in. Leadership-relevant decision tasks and comparison with your own baseline are central to the procedure. Conventional neuropsychological tests provide a supplementary comparison and control layer. The focus is on individual change, rather than a blanket judgement of suitability.

A shared commitment.
Two perspectives.

A personal medical interpretation for the CEO. A clearly limited status report for the commissioning supervisory board.

01

Executives & CEOs

Are you changing how you value rewards, commit effort, weigh risks or develop solutions? We track these changes against your personal baseline and interpret them in a medical context.

For executives
A CEO explains his decision in a stock-market scenario with falling prices and red price changes on a wall display, observed by two specialists in a conference room with a laboratory behind glass.
How would you decide under these conditions?
02

Supervisory boards

Your board receives a status report agreed in advance: Stable, Review or Material Change. It describes change relative to the CEO’s personal baseline; detailed medical findings are kept separate.

For supervisory boards
Seven people in discussion around a large oval conference table.

Long-term monitoring of individual decision-making behaviour.

A long-term engagement connects your personal baseline with annual and event-triggered reassessments. Continuity, medical interpretation and an independent second review keep your individual trajectory in focus.

  1. 01

    An individual baseline

    Two initial assessments establish the personal reference point.

  2. 02

    Annual and event-triggered reassessments

    Track changes against the individual’s own starting point.

  3. 03

    Professional assessment and independent second review

    Interpret results against consistent criteria; keep personal feedback and the status report separate.

Track changes. Understand the medical context.

Personal findings for the CEO. An agreed status for the board.

A closed petrol-coloured document folder with the gold CDDI Group logo on a walnut table.
Next step

Keep the person behind critical decisions in focus.

Make the person behind critical business decisions part of your long-term perspective. Discuss your personal baseline, ongoing monitoring and reporting arrangements with us.

Arrange a confidential conversation